The relationship between pathology in the brain and alterations in the gut microbiome could lead to therapies — even if it’s ...

Emerging research highlights the underexplored role of gut neuropeptides in Parkinson’s disease, revealing new connections ...

Parkinson’s Disease is a neurodegenerative disorder that affected predominately the Dopamine-producing neurons in a specific ...

Parkinson’s Disease is commonly known as a movement disorder that affects the nervous system. But professionals say one ...

Currently, over 10 million people worldwide are living with Parkinson’s disease, a progressive neurodegenerative disorder ...

Europe’s flawed oversight of pesticides may be fueling a silent epidemic, warns Dutch neurologist Bas Bloem. His fight for reform pits him against industry, regulators — and time.

In a first-of-its-kind human trial, researchers transplanted iPS-cell-derived dopaminergic progenitors into patients with ...

DelveInsight’s analysis forecasts Parkinson’s disease market growth due to the introduction of emerging therapies, expecting a rise in market size during the study period (2020–2034). The anticipated ...

Parkinson’s disease primarily affects dopamine neurons in the substantia nigra, a region of the brain crucial for movement and emotional regulation. As these neurons die, the brain’s dopamine levels ...